# Clinical Characterization of Symptomatic Populations

> **NCT03319212** · NA · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 105 (actual)

## Conditions studied

- Ametropia

## Interventions

- **DEVICE:** senofilcon A contact lenses

## Key facts

- **NCT ID:** NCT03319212
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-29
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-08-15
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2019-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03319212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03319212, "Clinical Characterization of Symptomatic Populations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03319212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*